We're Here for You!
The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure.
In this week’s blog, IMF Chairman of the Board and Chief Scientific Officer Dr. Brian G.M. Durie highlights the importance of keeping abreast with what’s happening in the news, especially significant developments in the field of myeloma. Dr. Durie also emphasizes the value of being in a collaborative myeloma community—a mainstay of achieving the best for all patients across the U.S. on an ongoing basis. READ THE BLOG.
The 2023 Brian D. Novis Research Grants are now accepting applications. BDN Grants are awarded to researchers working in the field of multiple myeloma and related disorders, including smoldering multiple myeloma (SMM), monoclonal gammopathy of undetermined significance (MGUS), and immunoglobulin-derived amyloidosis. Deadline for submission is September 1, 2022. APPLY NOW.
The IMF Patient & Family Webinar (PFS) – Back to Basics: From Testing to Tailored Therapy will be held on Saturday, August 20 at 10 a.m. PST/11 a.m. MST/12 p.m. CT/ 1 p.m. ET. Topics to be discussed include Recommended Testing and Monitoring: 2022 Algorithms, Frontline Options, Managing Myeloma Care, and Relapse Options: FDA Approved/Clinical Trials. REGISTER NOW.
The IMF Regional Community Workshop (RCW) – East South Central was held on Saturday, August 6. The workshop included an introduction to myeloma, upfront treatments at diagnosis, maintenance therapy, relapse information, an update on clinical trials, and more. In case you missed it, you can still watch the replay. WATCH NOW.
Las Voces de Mieloma Support Group (Spanish/Virtual), Monday, August 15, 10:00 a.m.—11:00 a.m. PST. Guest speaker: Dr. Ruben Niesvizky, Director of the Multiple Myeloma Center at Weill Cornell Medicine/New York-Presbyterian Hospital. Join us by registering at https://www.myeloma.org/support-group/las-voces-de-mieloma. For any questions, please email [email protected]. REGISTER NOW.
Our hearts go to all innocent victims of the ongoing conflict in Ukraine.
As a global organization, the International Myeloma Foundation supports — and will continue to support — every myeloma patient, caregiver, doctor, researcher, and advocate going through struggles and difficulties brought about by the war in Ukraine.
As an advocate for hope and resilience among the members of the myeloma community, the IMF is here for you — and even to a greater degree, during this most difficult time.
Our mission is clear, and our steadfast commitment continues — to improve the quality of life of myeloma patients across the globe, while working toward prevention and a cure.
Need assistance in creating a fundraiser? The IMF team is here for you. Find out how you can help in the fight against myeloma today!